A new analysis in the journal Nature reports that shifts in gene expression with age may raise men’s susceptibility to several cancers. The study examines how genes switch on and off over time and ties those changes to tumor risk. Researchers say the findings could guide screening and prevention for older men.
The work, conducted across large genetic datasets, compares patterns seen in adult men and women. It finds that age intensifies certain biological pathways in men that align with known cancer drivers. The authors point to potential differences in immune activity, DNA repair, and inflammation as men grow older.
What the Study Says
Study of gene expression also finds age-related increases in men’s vulnerability to certain cancers.
By tracking gene activity against age, the team identified signals that map to higher cancer incidence in men. The effect was strongest in tumor types where men already face higher rates. That includes liver and bladder cancers, among others. The data suggest biology plays a larger role than previously measured lifestyle factors alone.
The authors analyzed thousands of samples to spot patterns that shift with aging. They report that several pathways tied to cell growth and chronic inflammation trend upward in older men. In contrast, some protective responses appear to hold steadier in women of the same age.
Long-Running Gender Gap in Cancer
Men have long been more likely to develop many cancers and to die from them. Epidemiologists have linked the gap to smoking, alcohol use, workplace exposures, and delayed care. But recent research has shown that behavior does not explain the full divide.
Prior studies have hinted at sex differences in immune response and DNA damage repair. This new work strengthens that case by tracking changes over the lifespan. It suggests that small shifts in gene activity, year by year, can add up to real risk.
- Men show higher rates for liver, bladder, esophageal, and head and neck cancers.
- Women are more likely to develop thyroid and some autoimmune-related cancers.
- Hormones, body fat distribution, and immune function differ by sex and age.
How Age May Tip the Scales
Gene expression is how a cell reads its DNA to make proteins. Small changes can accelerate cell division or dampen defenses that spot damaged cells. The study ties aging in men to stronger activity in pathways linked to growth signals and chronic inflammation.
Experts say these shifts could make it easier for tumors to form and grow. They also note that men often have higher visceral fat in midlife. That fat can fuel inflammation, which may amplify aging signals in tissues like the liver.
What It Means for Screening and Care
The findings could support more tailored screening for older men. Earlier checks for liver cancer in men with metabolic risk, for example, may catch disease sooner. Primary care visits could also include simple risk discussions that factor in age, sex, and family history.
Prevention still matters. Limiting alcohol, stopping smoking, managing weight, and getting vaccines such as hepatitis B can reduce risk. The study adds a biological reason to prioritize these steps for men as they age.
Limits and Open Questions
Researchers caution that the analysis links gene activity to risk but does not prove cause. Many datasets lack complete information on lifestyle, medications, or environmental exposure. More diverse cohorts are needed to confirm which pathways drive risk in different groups.
Scientists also want to know how hormones and the immune system interact with aging genes. Understanding that could reveal precise targets for drugs or prevention.
The Road Ahead
Next steps include testing whether these aging-linked signals can predict who benefits most from screening. Trials could see if lifestyle changes alter the gene pathways in older men. Labs may also look for biomarkers in blood that flag rising risk before a tumor forms.
For now, the message is clear. Biology shifts with age in ways that may leave men more exposed to certain cancers. Better screening schedules, stronger prevention, and closer monitoring could narrow the gap.
The study offers a practical takeaway for patients and clinicians. Discuss risk earlier, act on proven prevention, and watch for signs where men face higher rates. Future work will show whether targeting these aging signals can turn the tide.
